Asthenospermia: Causes, Diagnosis, and Treatment

Asthenospermia, more formally called asthenozoospermia, is the medical term for reduced sperm motility, meaning sperm don’t swim well enough to reliably reach and fertilize an egg. Under current World Health Organization criteria, the diagnosis applies when fewer than 42 percent of sperm in a semen sample show total motility or fewer than 30 percent show progressive (forward-moving) motility. It is one of the most common findings on a semen analysis for men being evaluated for infertility, and it can exist alone or alongside low sperm count or abnormal sperm shape. The condition has a wide range of causes, from genetic defects and varicocele to lifestyle habits and chemical exposures, and the treatment strategy depends entirely on which cause is driving the problem.

How Sperm Motility Works and Why It Matters

A sperm cell moves by whipping its tail, or flagellum, in a coordinated wave pattern. That motion depends on a sophisticated internal scaffold called the axoneme, a tube-like structure running down the center of the flagellum and built from protein filaments called microtubules. Molecular motors called dyneins attach along these filaments and generate force by sliding them against each other. Research using advanced imaging on sea urchin sperm has shown that bending is produced not by switching dynein motors “on” on one side, as long assumed, but by selectively inhibiting them on the opposite side, creating an asymmetric force that curves the tail.¹ When any piece of this machinery is defective, the tail can’t beat properly and sperm motility drops.

Energy for flagellar beating comes mainly from mitochondria packed tightly in the midpiece of the sperm tail. These mitochondria convert nutrients into usable fuel. When mitochondria malfunction, they not only produce less energy but also become the primary source of damaging reactive oxygen species in the sperm cell, setting up a vicious cycle in which low energy and oxidative damage reinforce each other.² Understanding this two-part system, the structural engine and the energy supply, helps explain why so many different problems can ultimately produce the same result: sperm that swim poorly or not at all.

Genetic and Structural Causes

Some men are born with genes that build defective flagellar components. The best-studied genetic link is primary ciliary dyskinesia, a condition affecting motile cilia throughout the body. Because sperm tails share much of the same molecular architecture as cilia in the lungs and elsewhere, the same gene mutations that cause chronic respiratory problems can also cause poor sperm motility.³ Research has documented male infertility linked to mutations in at least 22 genes associated with primary ciliary dyskinesia, though patient numbers remain small and the exact structural effects on the sperm tail are still poorly understood in many cases.⁴

Separate from primary ciliary dyskinesia, a growing list of gene mutations cause a pattern known as multiple morphological abnormalities of the flagella, in which sperm tails are short, absent, bent, or structurally disordered. Mutations in at least 13 genes have been linked specifically to this flagellar defect pattern so far.⁴ A recent case report identified a new mutation in a gene called LRRC6 in a family where affected men had both asthenospermia and primary ciliary dyskinesia. Electron microscopy of their sperm revealed missing dynein arms and incomplete mitochondrial coverings in the flagellar midpiece, essentially crippling both the motor and the power supply.⁵

Beyond structural gene defects, emerging research points to epigenetic disruptions, changes in how genes are regulated rather than in the genes themselves, as a contributing factor. Abnormalities in DNA packaging, methylation patterns, and small RNA molecules carried by sperm have all been associated with male infertility, though the field is still working out which of these changes actually cause motility problems and which are just along for the ride.

Varicocele

A varicocele is an enlargement of veins within the scrotum, somewhat like varicose veins in the leg. It is remarkably common, found in roughly 15 percent of all men and up to 40 percent of men evaluated for infertility. The leading theory is that pooled blood in these dilated veins raises scrotal temperature and reduces oxygen supply, triggering oxidative stress that damages sperm. A systematic review and meta-analysis of animal studies confirmed that varicocele significantly increases testicular oxidative stress markers while simultaneously reducing sperm quality.⁶ Because it is both common and treatable, varicocele is typically one of the first things a urologist looks for when evaluating asthenospermia.

Infections and Inflammation

Infections of the reproductive tract, whether caused by bacteria, mycoplasma, or other organisms, are an underappreciated cause of poor sperm motility. When the immune system responds to an infection in the prostate, epididymis, or seminal vesicles, it releases signaling molecules called cytokines and white blood cells into the seminal fluid. At normal background levels, certain cytokines support sperm function. At the elevated levels produced during infection or inflammation, they become harmful.⁷

Studies measuring cytokine concentrations in seminal plasma have found that levels of inflammatory markers were significantly higher in men with urogenital infections, and these elevated levels correlated with lower numbers of progressively motile sperm.⁸ What makes this particularly tricky is that reproductive tract inflammation often occurs without obvious symptoms. A man may have no pain, no discharge, and no fever, yet chronic low-grade infection can quietly impair sperm motility for months or years.⁷ When infection is identified and treated with appropriate antibiotics, motility sometimes recovers, though the evidence for this is inconsistent and depends heavily on the specific organism and duration of infection.

Environmental Exposures and Lifestyle Factors

Chemical exposure is an increasingly recognized contributor to poor sperm motility. Endocrine-disrupting chemicals, substances that interfere with the body’s hormonal signaling, are found in a wide range of everyday products and industrial settings. Metabolites of industrial chemicals have been detected directly in seminal plasma, and their presence is associated with disrupted sperm development and maturation.⁹ Well-documented culprits include phthalates (found in plastics and personal care products), bisphenols, certain pesticides, and flame retardants.¹⁰

On the lifestyle side, obesity, diabetes, and metabolic syndrome each independently hurt sperm quality. A systematic review found that all three conditions negatively affect semen parameters and sperm DNA integrity, with lifestyle interventions like exercise generally improving male fertility markers, though the type and intensity of exercise appear to matter.¹¹ Smoking is another well-documented factor, and chronic diseases beyond diabetes can also play a role.¹⁰ The frustrating reality is that for many men with asthenospermia, there is no single smoking-gun cause. Instead, a combination of mild genetic predispositions, moderate environmental exposure, and a few lifestyle risk factors conspire to push motility below the threshold.

How Asthenospermia Is Diagnosed

Diagnosis starts with a standard semen analysis, ideally performed on at least two samples collected a few weeks apart, since sperm parameters fluctuate naturally from one ejaculate to the next. A lab technician evaluates concentration, morphology (shape), and motility. Motility is classified into progressive (sperm moving forward), non-progressive (moving but not going anywhere), and immotile. The WHO’s lower reference limit for total motility is 42 percent, and for progressive motility it is 30 percent. Falling below those thresholds earns the diagnosis.

Manual semen analysis is somewhat subjective, so many clinics now also use computer-assisted sperm analysis, or CASA. These systems track individual sperm through a microscope using video analysis and calculate precise movement parameters such as curvilinear velocity, straight-line velocity, and the wobble of the sperm’s path.¹² CASA provides more reproducible measurements than a technician counting and categorizing sperm by eye, and it can detect subtle kinematic abnormalities that a standard analysis misses. It has also proven useful for objectively measuring changes after treatment, for example after varicocele repair.¹³

Beyond motility testing, clinicians may order hormonal panels, ultrasound of the scrotum to check for varicocele, urine or semen cultures to look for infection, and genetic testing if structural flagellar defects are suspected. An emerging area is seminal plasma metabolomics, in which researchers analyze the small molecules present in seminal fluid to look for metabolic fingerprints characteristic of asthenospermia. Studies have found patterns of altered amino acids, lipids, cholesterol metabolites, and energy-cycle intermediates that reliably distinguish men with asthenospermia from fertile controls.¹⁴ One recent study even identified three distinct metabolic subtypes of the condition, each with a different pattern of disrupted pathways, suggesting that what we call “asthenospermia” may actually be several different metabolic problems grouped under one umbrella.¹⁵ These metabolomic tools are not yet routine clinical tests, but they point toward a future in which treatment could be tailored to a man’s specific metabolic subtype rather than prescribed generically for “low motility.”

Treating the Underlying Cause

When a specific cause is identified, treating it directly is the most effective approach. For varicocele, surgical repair (varicocelectomy) or a less invasive procedure called scleroembolization can restore normal blood flow. Studies consistently show significant improvements in sperm concentration, progressive motility, and total motile sperm count after varicocele treatment.¹⁶ One retrospective study found that total motile sperm count roughly tripled after the procedure.¹⁷ It typically takes three to six months after repair for semen parameters to improve, since a full cycle of sperm production lasts about 72 days. If motility hasn’t improved by that point, other strategies should be considered.¹⁸

For infection-related asthenospermia, targeted antibiotics are the first step, though recovery of motility isn’t guaranteed, especially after prolonged infections that may have caused lasting tissue damage. For hormonal imbalances, correcting the underlying endocrine problem can sometimes restore motility. And for lifestyle-driven causes, weight loss, smoking cessation, better diet, and moderate exercise form the baseline intervention. These changes don’t produce overnight results but can meaningfully shift semen parameters over a period of months.

Antioxidant Supplementation

Because oxidative stress is implicated in so many cases of asthenospermia, antioxidant supplements have become one of the most commonly recommended interventions, especially for men with “idiopathic” cases where no clear cause has been found. Coenzyme Q10 (CoQ10) is one of the better-studied options. It plays a dual role: it acts as an antioxidant to neutralize reactive oxygen species, and it serves as a critical component of the mitochondrial energy production chain. A study of men with idiopathic low motility and low count found that three months of CoQ10 supplementation significantly improved progressive and total motility, while reducing oxidative stress markers and boosting antioxidant capacity in seminal fluid.¹⁹

Other antioxidants commonly prescribed or recommended include vitamin E, vitamin C, selenium, zinc, L-carnitine, and N-acetylcysteine. The evidence for each varies in strength, and the overall literature is a patchwork of small trials with inconsistent designs. Still, most reproductive medicine specialists consider a trial of antioxidant supplementation a reasonable low-risk intervention while other evaluations and treatments proceed. The key caveat is that antioxidants help most when oxidative stress is genuinely the problem. For a man whose asthenospermia is caused by a structural gene defect, supplements are unlikely to move the needle.

Assisted Reproduction When Natural Conception Isn’t Working

When direct treatment either fails or isn’t feasible, assisted reproductive technologies offer pathways to pregnancy. The options exist on a spectrum of complexity. Intrauterine insemination places washed, concentrated sperm directly into the uterus, reducing the distance sperm need to travel. Standard in vitro fertilization (IVF) combines eggs and sperm in a dish. And intracytoplasmic sperm injection (ICSI) takes it a step further by injecting a single sperm directly into an egg, effectively bypassing the swimming requirement altogether.

For men with asthenospermia, ICSI has been a game-changer because it removes motility from the equation almost entirely. Even severely immotile sperm can be selected if they show signs of viability. Data from one fertility center found pregnancy rates for men with asthenospermia of roughly 54 percent with IVF, 32 percent with ICSI, and 13 percent with IUI, though these differences did not reach statistical significance in that particular study.²⁰ The numbers vary widely between clinics and depend heavily on female partner factors like age and egg quality.

In the laboratory, techniques for selecting the best sperm have grown more sophisticated. Traditional density gradient centrifugation separates sperm by weight, but newer microfluidic devices sort sperm through tiny channels that mimic the natural selection environment of the female reproductive tract. One comparison found that a microfluidic device called ZyMōt produced sperm samples with higher motility, higher fertilization rates, and more good-quality embryos than the conventional method.²¹ Pharmacological agents like pentoxifylline are also sometimes used in the lab to stimulate motility in asthenozoospermic samples before ICSI, though concerns exist about premature acrosome reactions and possible toxicity to eggs and early embryos.

Photobiomodulation and Other Experimental Approaches

One of the more unexpected areas of research involves shining red or near-infrared light on sperm to boost their motility. The idea is that specific wavelengths of light stimulate mitochondrial activity, increasing energy production in the sperm cell. Laboratory studies have found that red light exposure can increase sperm swimming speed by 17 to 47 percent compared to untreated controls, with the effect appearing within about 35 minutes of irradiation and persisting throughout exposure.²² A comprehensive systematic review across multiple wavelength ranges found that most studies reported positive effects of light therapy on sperm motility.²³ A separate study comparing different durations of red light exposure confirmed significant increases in progressive motility and significant decreases in immotile sperm.²⁴

This technology is still largely experimental, and nearly all published work has been done in the lab rather than in large-scale clinical trials measuring pregnancy outcomes. But it’s a promising area, particularly as a way to improve sperm quality right before use in IVF or ICSI, where even a short-term boost in motility could make sperm selection easier. It’s a good example of how research into sperm bioenergetics is opening up treatment avenues that nobody anticipated a decade ago.

The Psychological Toll of a Diagnosis

The emotional side of asthenospermia deserves honest acknowledgment, because it frequently gets overlooked in clinical settings. Research consistently shows that male infertility is associated with significant psychological distress, including depression, anxiety, lower self-esteem, and strain on relationships and sexual function.²⁵ Cultural expectations that equate fertility with masculinity can amplify these feelings, particularly in social contexts where infertility carries stigma.²⁶

Many men report suppressing their emotions, avoiding conversations about infertility, and feeling isolated during the diagnostic and treatment process. This is compounded by the fact that fertility care is often structured around the female partner, with men feeling like supporting characters in a process that is, biologically, equally about them. If you or your partner are dealing with an asthenospermia diagnosis, it’s worth knowing that these feelings are common and well-documented, and that seeking psychological support isn’t a sign of weakness. Some fertility clinics now include counseling services as part of their standard care, and the evidence strongly suggests that men undergoing fertility treatment have their own distinct support needs that deserve attention.²⁵

1
PubMed Central. Asymmetric distribution and spatial switching of dynein activity generates ciliary motility
2
PubMed Central. Pathophysiology of Mitochondrial Dysfunction in Human Spermatozoa: Focus on Energetic Metabolism, Oxidative Stress and Apoptosis
3
PubMed. Genetic causes of bronchiectasis: primary ciliary dyskinesia
4
PubMed Central. Sperm defects in primary ciliary dyskinesia and related causes of male infertility
5
PubMed. A novel homozygous LRRC6 mutation causes male infertility with asthenozoospermia and primary ciliary dyskinesia in humans
6
PubMed Central. Impact of Varicocele on Testicular Oxidative Stress and Sperm Parameters in Experimental Animals: A Systematic Review and Meta-Analysis
7
PubMed Central. Impact of Inflammation on Male Reproductive Tract
8
PubMed. Cytokine levels in the seminal plasma of infertile males
9
PubMed Central. Endocrine disrupting chemicals and male fertility: from physiological to molecular effects
10
PubMed Central. Environmental and occupational exposures associated with male infertility
11
PubMed. The impact of obesity and metabolic health on male fertility: a systematic review
12
Hittite Journal of Science and Engineering. Assessment of Human Sperm Kinematic Parameters Using Computer-Assisted Semen Analysis
13
PubMed Central. Computer-aided sperm analysis: a useful tool to evaluate patient’s response to varicocelectomy
14
PubMed. Metabolic characterization of asthenozoospermia using nontargeted seminal plasma metabolomics
15
PubMed. Diagnostic classification and medical decision of idiopathic asthenozoospermia based on metabolomics analysis of seminal plasma
16
PubMed Central. Improvement of sperm morphology after surgical varicocele repair
17
PubMed Central. Predictive parameters of semen outcome improvement after varicocele treatment by scleroembolization: a retrospective study
18
PubMed Central. Clinical Outcomes of Varicocele Repair in Infertile Men: A Review
19
PubMed Central. Coenzyme Q10 improves sperm motility and antioxidant status in infertile men with idiopathic oligoasthenospermia
20
PubMed Central. The Outcome of Assisted Reproductive Techniques among Couples with Male Factors at Prince Khalid Bin Sultan Fertility Centre, Kingdom of Saudi Arabia
21
PubMed Central. Comparative Evaluation of Two Microfluidic Sperm Sorting Devices: Laboratory Assessment of Sperm Quality and Retrospective Analysis of Embryological Outcomes Following Intracytoplasmic Sperm Injection
22
PubMed Central. Red light improves spermatozoa motility and does not induce oxidative DNA damage
23
PubMed. A Comprehensive Systematic Review of the Effects of Photobiomodulation Therapy in Different Light Wavelength Ranges (Blue, Green, Red, and Near-Infrared) on Sperm Cell Characteristics in Vitro and in Vivo
24
PubMed. Effects of photobiomodulation therapy on human sperm function
25
PubMed Central. Psychological consequences of a diagnosis of infertility in men: a systematic analysis
26
PubMed Central. The Psychological Impact of Male Infertility: A Narrative Review